Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-001334
Filing Date
2023-01-23
Accepted
2023-01-23 18:02:49
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 form4-01232023_110138.html 4  
1 form4-01232023_110138.xml 4 6557
  Complete submission text file 0001415889-23-001334.txt   7893
Mailing Address 4362 24TH STREET SAN FRANCISCO CA 94114
Business Address
Santel Donald J (Reporting) CIK: 0001293630 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 23545446

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations